Literature DB >> 3711911

Parvalbumin in cat brain: isolation, characterization, and localization.

C C Stichel, U Kägi, C W Heizmann.   

Abstract

Because of the increasing evidence that Ca2+-binding proteins have important regulating functions in nerve cells and because of the indications that there are species differences in the structures of these proteins, parvalbumin was purified from cat brain and muscle. Brain and muscle parvalbumins were found to be indistinguishable from each other in their biochemical and immunological properties. However, cat parvalbumin differs from all other mammalian parvalbumins by its apparently lower Mr on sodium dodecyl sulfate-polyacrylamide gel electrophoresis of 10-11K (compared to rat parvalbumin, 12K), and a lower pI of 4.6 (rat parvalbumin, 4.9), in the tryptic peptide maps, and in the immunological properties, indicating a distinct primary structure. With the purified parvalbumin as antigen, polyclonal antibodies were raised in rabbits and these were subsequently used for immunohistochemical localizations of parvalbumin in the cat brain. In the visual cortices of adult cats immunoreactive neurons were present throughout layers II and IV. In cerebellar cortex, Purkinje, basket, and stellate cells were immunoreactive. Comparison with staining patterns obtained with antiserum against rat parvalbumin revealed some cross-reactivity but confirmed the existence of species differences in the antigenic structure of rat and cat parvalbumin.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3711911     DOI: 10.1111/j.1471-4159.1986.tb02829.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  10 in total

1.  Large nerve cells with long axons in the granular layer and white matter of the murine cerebellum.

Authors:  T Müller
Journal:  J Anat       Date:  1994-04       Impact factor: 2.610

2.  Cell-specific immuno-probes for the brain of normal and mutant Drosophila melanogaster. I. Wildtype visual system.

Authors:  E Buchner; R Bader; S Buchner; J Cox; P C Emson; E Flory; C W Heizmann; S Hemm; A Hofbauer; W H Oertel
Journal:  Cell Tissue Res       Date:  1988-08       Impact factor: 5.249

3.  Expression of immunoreactivity for Ca-binding protein, spot 35 in the interstitial cell of the rat pineal organ.

Authors:  M Yamamoto; H Kondo; T Yamakuni; Y Takahashi
Journal:  Histochem J       Date:  1990-01

Review 4.  Calcium-binding proteins: selective markers of nerve cells.

Authors:  C Andressen; I Blümcke; M R Celio
Journal:  Cell Tissue Res       Date:  1993-02       Impact factor: 5.249

5.  Appearance of parvalbumin-specific immunoreactivity in the cerebral cortex and hippocampus of the developing rat and gerbil brain.

Authors:  A Seto-Ohshima; E Aoki; R Semba; P C Emson; C W Heizmann
Journal:  Histochemistry       Date:  1990

6.  Parvalbumin-immunoreactive neurons in the human central nervous system are decreased in Alzheimer's disease.

Authors:  J Satoh; T Tabira; M Sano; H Nakayama; J Tateishi
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

7.  Neuroanatomical identification of crossmodal auditory inputs to interneurons in somatosensory cortex.

Authors:  Leslie P Keniston; Scott C Henderson; M Alex Meredith
Journal:  Exp Brain Res       Date:  2010-01-20       Impact factor: 1.972

8.  Differential Ca2+ binding properties in the human cerebellar cortex: distribution of parvalbumin and calbindin D-28k immunoreactivity.

Authors:  A L Scotti; C Nitsch
Journal:  Anat Embryol (Berl)       Date:  1992

9.  Development of parvalbumin immunoreactive neurons in normal and intracranially transplanted retinas in the rat.

Authors:  Q X Guo; M C Yu; L J Garey; L S Jen
Journal:  Exp Brain Res       Date:  1992       Impact factor: 1.972

10.  Molecular layer interneurons shape the spike activity of cerebellar Purkinje cells.

Authors:  Amanda M Brown; Marife Arancillo; Tao Lin; Daniel R Catt; Joy Zhou; Elizabeth P Lackey; Trace L Stay; Zhongyuan Zuo; Joshua J White; Roy V Sillitoe
Journal:  Sci Rep       Date:  2019-02-11       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.